News
The company plans to use the funding to expand its commercial team, scale operations and develop new products.
The test reports on the G84E mutation in the HOXB13 gene, which studies have shown increase a person’s risk of developing prostate cancer.
Users can tap into the system to measure their blood pressure, heart rate, heart variability rate and more.
The UAE-based asset owner and investor has announced it is to consolidate several healthcare companies within Pure Health.
MobiHealthNews rounds up all of the new digital health technologies released at CES this year.
The growth of telehealth and remote-monitoring tools could be a game-changer for women's health, particularly maternal and fetal care.
Both companies are focused on using voice technology to assist seniors at home.
During a panel at CES, leaders at digital therapeutic companies discuss the state of the market right now and what’s needed to boost adoption.
GP who advised on controversial NHS data sharing plan receives damehood.
The company is selling the devices for $2,950.